CAS 151250-76-9

(S)-9-Fluoro-2,3-dihydro-3-Methyl-10-[[2-(Methylamino)ethyl]amino]-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid

CAS: 151250-76-9

Formel: C₁₆H₁₈FN₃O₄

Reinheit: 95%

Farbe und Form: Solid

Molekulargewicht: 335.3302

Ref: IN-DA003AL3

(S)-9-Fluoro-3-methyl-10-((2-(methylamino)ethyl)amino)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid

CAS: 151250-76-9

(S)-9-Fluoro-3-methyl-10-((2-(methylamino)ethyl)amino)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid

Reinheit: 95%

Molekulargewicht: 335.34g/mol

Ref: 54-PC1003124

Levofloxacin EP Impurity G (Levofloxacin USP Related Compound E (Free Form), N,N'-Desethylene Levofloxacin)

CAS: 151250-76-9

Formel: C₁₆H₁₈FN₃O₄

Farbe und Form: Pale Yellow Solid

Molekulargewicht: 335.34

Ref: 4Z-L-237

Levofloxacin impurity

CAS: 151250-76-9

Levofloxacin is a drug product that is used to treat bacterial infections. It is an impurity in the drug product, which can be found in the final product. Levofloxacin impurity has been detected by LC-MS/MS and GC-MS analysis. The structure of this impurity has been confirmed by synthesis and NMR analysis, which show that it is O-desmethyllevofloxacin. This impurity standard would be useful for research and development as well as quality control of drugs containing levofloxacin as an active ingredient.

Formel: C₁₆H₁₈FN₃O₄

Reinheit: Min. 95%

Molekulargewicht: 335.33 g/mol

Ref: 3D-BGA25076